metsera glp 1 Metsera's Once Monthly GLP-1 Shot Looking Better than Zepbound in Early Trials Healthy Returns: Pfizer's new obesity

Investigating nutrient intake during use of glucagon-like peptide-1 receptor agonist: a cross-sectional study

Is semaglutide safer than SGLT-2 inhibitors for UTI-prone people

Preparing the patient for what to expect fosters realistic expectations, builds trust, and encourages adherence to therapy

2 Accordingly, the observed decline in male reproductive function is likely driven, at least in part, by the growing burden of chronic disease, including obesity and related comorbidities such as type 2 diabetes, which are increasingly linked to adverse reproductive and fertility outcomes

Monica : It just happened very organically